All studies
RecruitingHuman Pharmacology (Phase I)- OtherInterventional

Bioavailability Comparison of Finerenone 20 mg Tablets (Test vs. Comparator Product).

This clinical trial looks at finerenone, a medicine used to help protect the kidneys and heart. The main goal is to compare a new 20 mg finerenone tablet against an approved, standard tablet. Researchers want to confirm that both tablets behave in the same way inside the human body. This is called a bioavailability study. It measures how much of the medicine enters your bloodstream and how fast it gets there. To make the test fair and accurate, participants will take each tablet on an empty stomach after fasting overnight. Medical staff will collect blood samples at regular times to track the medicine levels. Studies like this are vital because they help make sure that newer or generic versions of essential treatments are just as safe and effective as the original, helping to keep medicines accessible and affordable.

At a glance

Status
Recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Enrolment target
52
Start
12 Aug 2026

What is this study about?

Finerenone is a modern medicine that doctors use to treat kidney disease, particularly in people who also have diabetes. It works by blocking certain chemical signals in the body that can cause inflammation and tissue scarring in the kidneys and heart. In this study, scientists are testing a new 20 mg tablet version of finerenone to see how it compares to the version that is already widely prescribed.

When a company makes a new version of an existing drug, they must prove that it delivers the exact same amount of active medicine into the bloodstream at the same speed. This property is known as 'bioavailability'. If the new tablet matches the original, doctors can be confident that it will work just as well and have the same safety profile for patients.

To get a clear and reliable reading, the study takes place under 'fasting conditions'. Food can change how quickly our stomachs break down pills and absorb treatments. By asking participants to skip food overnight before taking the tablet, researchers ensure that every dose is absorbed in a clean, controlled setting without meals getting in the way.

Phase 1 trials like this are an essential step in bringing safe, high-quality, and often lower-cost generic medicines to the NHS. By taking part or following this research, you are learning about how health authorities verify that everyday tablets meet the highest possible safety standards.

Key takeaways

  • Compares a new 20 mg finerenone tablet against an established version.
  • Aims to prove both tablets deliver medicine into the body in the same way.
  • Open to adults aged 18 and older who meet the health criteria.
  • Requires overnight fasting and multiple blood tests to track drug levels.
  • Helps bring reliable, high-quality, and affordable medicines to patients.

Who may be eligible?

This trial is open to adults aged 18 and older of any sex. Because this is an early-stage study designed to measure how a medicine moves through the body, researchers typically look for people who are in good general health.

To be suitable, you must be comfortable fasting overnight before test days and happy to have multiple routine blood samples taken. You should also be able to follow specific clinic instructions regarding diet, drink, and daily activities during the test visits.

You may not be eligible if you take certain regular prescription drugs, have allergies to finerenone, or live with severe medical conditions that could interfere with how your body absorbs or clears medicines. A trial doctor will review your full medical history before you can join.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you aged 18 or older?
  2. Are you in good general health?
  3. Are you comfortable fasting overnight before study visits?
  4. Are you willing to have regular blood samples taken from your arm?
  5. Are you able to attend clinic visits over a period of a few weeks?
Answer every question to see your result.

What does participation involve?

Taking part usually involves an initial screening visit to check your general health, blood pressure, and medical history. During the study, you will visit a specialist clinic or stay for a short period. You will fast overnight and take a single 20 mg finerenone tablet with water in the morning. Over the next 24 to 48 hours, the clinical team will take small blood samples at set times to measure the drug levels in your system. In most comparison studies of this kind, you will repeat the process a week or two later with the other tablet so researchers can compare both. The entire study typically lasts a few weeks from the first check-up to a final health review.

Potential risks and benefits

You are unlikely to gain any direct personal health benefits from taking part in this early test, but your participation helps ensure safe and reliable medicines are available for the future. The risks are generally low, but you may experience mild side effects from finerenone, such as light-headedness, low blood pressure, or temporary changes in your body's salt levels. Having blood taken can also cause slight bruising or discomfort. You are free to withdraw from the trial at any point, for any reason, without giving an explanation and without it affecting your standard NHS care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Czechia

Common questions

What is finerenone used for?

Finerenone is a tablet that helps protect the kidneys and heart from long-term damage, particularly in adults with chronic kidney disease.

What does 'bioavailability' mean?

It refers to how quickly and how much of a medicine gets absorbed into your bloodstream after you swallow it.

Why do I need to fast before taking the tablet?

Food can speed up or slow down how your stomach absorbs medicines. Fasting ensures that the test results are fair, accurate, and easy to compare.

Will taking part hurt?

Swallowing the tablet should not cause pain, but you may feel a brief pinch when blood samples are taken, and your arm might feel slightly bruised afterwards.

Can I leave the study early if I change my mind?

Yes. Joining a clinical trial is entirely voluntary, and you can stop taking part at any time without any penalty.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Bioavailability Comparison of Finerenone 20 mg Tablets (Test…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.